Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era: comment

被引:1
|
作者
Kapoor, Kapil G. [1 ]
Gibran, Syed K. [1 ]
机构
[1] Univ Texas Med Branch Galveston, Dept Ophthalmol & Visual Sci, Galveston, TX USA
来源
关键词
D O I
10.1111/j.1442-9071.2011.02597.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:918 / 919
页数:2
相关论文
共 50 条
  • [11] The development of tuberculosis in patients receiving highly active anti-retroviral therapy for HIV infection
    Breen, RAM
    Smith, CJ
    Cropley, I
    Johnson, MA
    Lipman, MCI
    THORAX, 2004, 59 (01) : 37 - 37
  • [12] Trends in pediatric ICU admissions and mortality in children with HIV/AIDS Pre & Post-HAART (highly active anti-retroviral therapy)
    Mathur, Mudit
    Shah, Vikas
    Piecuch, Steven
    Goldman, Gilbert M.
    Desai, Ninad
    CRITICAL CARE MEDICINE, 2007, 35 (12) : A248 - A248
  • [13] Retention in HIV care in the era of highly active anti-retroviral therapy (ART) for all HIV-1-infected individuals
    O'Connell, S.
    Lynam, A.
    O'Rourke, A.
    Sweeney, E.
    Sadlier, C.
    Bergin, C.
    HIV MEDICINE, 2016, 17 : 54 - 54
  • [14] Identifying risk factors of immune reconstitution inflammatory syndrome in AIDS patients receiving highly active anti-retroviral therapy
    He, Bo
    Zheng, Yuhuang
    Liu, Meng
    Zhou, Guoqiang
    Chen, Xia
    Mamadou, Diallo
    He, Yan
    Zhou, Huaying
    Chen, Zi
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (02): : 170 - 173
  • [15] Characteristics and Outcomes of HIV-Infected Patients With Severe Sepsis: Continued Risk in the Post-Highly Active Antiretroviral Therapy Era
    Cribbs, Sushma K.
    Tse, Caroline
    Andrews, Joel
    Shenvi, Neeta
    Martin, Greg S.
    CRITICAL CARE MEDICINE, 2015, 43 (08) : 1638 - 1645
  • [16] Diabetes Mellitus and Associated Factors Among Adult HIV Patients on Highly Active Anti-Retroviral Treatment
    Duguma, Fanta
    Gebisa, Waqtola
    Mamo, Aklilu
    Tamiru, Dessalegn
    Woyesa, Shiferaw
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2020, 12 : 657 - 665
  • [17] Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
    Mark E. Sharkey
    Ian Teo
    Thomas Greenough
    Natalia Sharova
    Katherine Luzuriaga
    John L. Sullivan
    R. Pat Bucy
    Leondios G. Kostrikis
    Ashley Haase
    Claire Veryard
    Raul E. Davaro
    Sarah H. Cheeseman
    Jennifer S. Daly
    Carol Bova
    Richard T. Ellison
    Brian Mady
    Kwan Kew Lai
    Graeme Moyle
    Mark Nelson
    Brian Gazzard
    Sunil Shaunak
    Mario Stevenson
    Nature Medicine, 2000, 6 : 76 - 81
  • [18] Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
    Sharkey, ME
    Teo, I
    Greenough, T
    Sharova, N
    Luzuriaga, K
    Sullivan, JL
    Bucy, RP
    Kostrikis, LG
    Haase, A
    Veryard, C
    Davaro, RE
    Cheeseman, SH
    Daly, JS
    Bova, C
    Ellison, RT
    Mady, B
    Lai, KK
    Moyle, G
    Nelson, M
    Gazzard, B
    Shaunak, S
    Stevenson, M
    NATURE MEDICINE, 2000, 6 (01) : 76 - 81
  • [19] Epidemiology, prevalence, and associated factors of oral candidiasis in HIV patients from southwest Iran in post-highly active antiretroviral therapy era
    Erfaninejad, Maryam
    Zarei Mahmoudabadi, Ali
    Maraghi, Elham
    Hashemzadeh, Mohammad
    Fatahinia, Mahnaz
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [20] CORRELATES OF SELF-REPORTED HYPERTENSION IN PATIENTS WITH AIDS IN THE ERA OF HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY (HAART)
    Krauskopf, Katherine
    Van Natta, Mark L.
    Federman, Alex
    Branch, Andrea D.
    Meinert, Curtis L.
    Jabs, Douglas A.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2012, 27 : S149 - S150